Digitek Recall

on April 25, 2008, Digitek was recalled because of concerns that the medicine could contain twice the appropriate level

April 25, 2008, Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Group, has initiated a Class I nationwide recall of Digitek (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a “Bertek” label and by UDL Laboratories, Inc. under a “UDL” label.

The Digitek recall was initiated it was learned that tablets contained twice the level of the active ingredient. Taking more than the safe level of Digitek can lead to Digitek toxicity.

information for patients

Patient inquiries related to the should be addressed to Stericycle customer service at 1-888-276-6166 with representatives available Monday through Friday, 8 am to 5 pm EST.

information for suppliers

Retailers who have this product are urged to return the product to their place of purchase.

Do you have a claim?

If you or your loved one has suffered a serious injury or death as a result of , you may be entitled to compensation for medical expenses, loss of wages, and pain and suffering.

Please contact our Digitek lawyers today by filling out the brief questionnaire, or by calling our toll free number (1-800-898-2034) for a free, no-cost, no-obligation legal evaluation of your case.